Advertisement

Topics

Lipid Panel Test Market: By Disease Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease, By EndUser Home Based Testing Kits, Diagnostic Laboratories, Hospital By RegionForecast 20162021 [Updated: 230

22:02 EDT 20 Jun 2017 | BioPortfolio Report Blog

Lipid profile test LPT, or total lipid profile or lipid panel is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, such as cholesterol and triglycerides. This test enables diagnosis of lipid disorders along with risk for coronary heart disease. There is a high correlation between coronary heart diseases CHD with abnormal lipid levels. These tests provides value for serum lipids such as total cholesterol, TG, HDL cholesterol, and VLDL. LPT market includes diagnostic services along with equipment and consumables such as analyzers, integrated systems, and lipid profile cassettes. The results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases. Globally increasing cases of dyslipidemia, cardiovascular diseases, and hypertension is expected to drive the demand for lipid profile tests during the period of s tudy.

Lipid Panel Test Market

Geographically North America dominated global lipid panel test market driven by best in the class healthcare infrastructure, advanced facilities and awareness and openness amongst citizens towards the availability of the treatment and higher spending by citizens on the healthcare. North America was followed by Europe and AsiaPacific as second and third largest market for lipid panel test market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global lipid panel test market size in for the year 20142016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global lipid panel test market.

This report segments global lipid panel test market on the basis of disease, enduser and regional market as follows:

Lipid Panel Test Market, By Disease: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease
Lipid Panel Test Market, By EndUser: Home Based Testing Kits, Diagnostic Laboratories, Hospital
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, AsiaPacific APAC, and Rest of the World RoW covering all the major country level markets in each of the region


This report identifies all the major companies operating in the lipid panel test market. Some of the major companies' profiles in detail are as follows:

Abbott Laboratories
Avanti Polar Lipids, Inc.
Beckman Coulter, Inc.
EuroMedixPOC nv/sa
F. HoffmannLa Roche Ltd

Original Article: Lipid Panel Test Market: By Disease Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease, By EndUser Home Based Testing Kits, Diagnostic Laboratories, Hospital By RegionForecast 20162021 [Updated: 230

NEXT ARTICLE

More From BioPortfolio on "Lipid Panel Test Market: By Disease Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease, By EndUser Home Based Testing Kits, Diagnostic Laboratories, Hospital By RegionForecast 20162021 [Updated: 230"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Lipitor
Lipitor was the best selling drug in 2009, with the 2009 annual sales coming in at over $5m for its company, Pfizer Inc. Lipitor is the brand name for an atorvastatin calcium medication that is prescribed to lower cholesterol and triglycerides in the the...